GSK, Hansoh Drug Delays Bone Cancer Progression in China Study
Researchers presented late-stage study data showing the companies’ experimental drug helped patients live longer without their bone cancer worsening.
By Bhanvi Satija and Sneha S KAn experimental drug for a hard-to-treat bone cancer, being developed by Hansoh Pharmaceutical HKEX:3692 and GSK LSE:GSK, helped patients live longer without the disease worsening, according to data presented by researchers at a medical meeting on Monday.Patients on ri…